Skip to main content
. 2022 Jul 22;37(4):652–663. doi: 10.3803/EnM.2022.1477

Fig. 2.

Fig. 2.

The frequency of telomerase reverse transcriptase (TERT) promoter mutations according to tumor size in 2,092 thyroid carcinoma patients.